Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 3, 2025 • 7:01 PM ET

Date/Time Source News Release
03/31/2025 08:30 AM EDT GlobeNewswire Veru to Participate in Fireside Chat at the Jones Healthcare and Technology Innovation Conference
02/13/2025 06:30 AM EST GlobeNewswire Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress
02/06/2025 08:30 AM EST GlobeNewswire Veru to Report Fiscal 2025 First Quarter Financial Results on February 13, 2025
02/04/2025 08:30 AM EST GlobeNewswire Veru to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
01/27/2025 06:30 AM EST GlobeNewswire Veru Announces Positive Topline Data from Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving WEGOVY® (Semaglutide) for Weight Reduction
12/31/2024 08:30 AM EST GlobeNewswire Veru Announces the Sale of the FC2 Female Condom® (Internal Condom) Business
11/26/2024 08:30 AM EST GlobeNewswire Veru to Present at the 17th International Conference of the Society on Sarcopenia, Cachexia, & Wasting Disorders
11/05/2024 08:30 AM EST GlobeNewswire Veru Announces Meta-analysis of Body Composition Data from Older Patients with Obesity which Supports Potential for Enobosarm to Optimize Weight Loss at ObesityWeek
10/21/2024 08:30 AM EDT GlobeNewswire Veru to Present at ObesityWeek: Meta-Analysis of 4 Previous Randomized Clinical Trials that Support the Potential of Enobosarm to Optimize Weight Loss
10/16/2024 08:30 AM EDT GlobeNewswire Veru to Deliver Keynote Presentation on the Scientific Support for Enobosarm in Combination with GLP-1 Receptor Agonist to Preserve Muscle for Higher Quality Weight Loss at the 4th Edition of the World Obesity and Weight Management Congress
Page

Additional News

As of April 3, 2025 • 7:01 PM ET

Date/Time Source News Release
04/01/2025 10:37 AM EDT 24/7 Market News Today's Leading Value Stock Gainers: KBLB, BIAF, STSS, RSLS, VERU, and HEPA
03/12/2025 09:55 AM EDT Zacks Here's Why Veru (VERU) Looks Ripe for Bottom Fishing
03/10/2025 12:21 PM EDT SeekingAlpha Viking, other obesity players fall following Novo Nordisk CagriSema results
03/08/2025 01:30 PM EST SeekingAlpha Weight-loss drug battle: Who are the latest players involved
03/06/2025 09:35 AM EST Zacks Down -9.23% in 4 Weeks, Here's Why Veru (VERU) Looks Ripe for a Turnaround
02/13/2025 02:36 PM EST SeekingAlpha Veru targets Phase 3 enobosarm trials following promising Phase 2b results in obesity treatment
02/13/2025 02:35 PM EST SeekingAlpha Veru Inc (VERU) Q1 2025 Earnings Call Transcript
02/13/2025 06:30 AM EST SeekingAlpha Veru GAAP EPS of -$0.01 beats by $0.06
02/13/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Thursday, February 13th, 2025
02/13/2025 04:30 AM EST US Earnings Reports Expected earnings - Veru Inc.
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.